Curaleaf Holdings (CURLF) Cash & Equivalents (2021 - 2025)
Curaleaf Holdings has reported Cash & Equivalents over the past 5 years, most recently at $101.6 million for Q4 2025.
- Quarterly results put Cash & Equivalents at $101.6 million for Q4 2025, down 5.27% from a year ago — trailing twelve months through Dec 2025 was $101.6 million (down 5.27% YoY), and the annual figure for FY2025 was $101.6 million, down 5.27%.
- Cash & Equivalents for Q4 2025 was $101.6 million at Curaleaf Holdings, down from $107.2 million in the prior quarter.
- Over the last five years, Cash & Equivalents for CURLF hit a ceiling of $299.3 million in Q4 2021 and a floor of $91.8 million in Q4 2023.
- Median Cash & Equivalents over the past 5 years was $107.2 million (2024), compared with a mean of $152.6 million.
- Biggest five-year swings in Cash & Equivalents: tumbled 45.49% in 2022 and later increased 16.78% in 2024.
- Curaleaf Holdings' Cash & Equivalents stood at $299.3 million in 2021, then tumbled by 45.49% to $163.2 million in 2022, then crashed by 43.73% to $91.8 million in 2023, then grew by 16.78% to $107.2 million in 2024, then decreased by 5.27% to $101.6 million in 2025.
- The last three reported values for Cash & Equivalents were $101.6 million (Q4 2025), $107.2 million (Q4 2024), and $91.8 million (Q4 2023) per Business Quant data.